Alnylam Pharmaceuticals
ALNY
#696
Rank
โ‚ฌ31.82 B
Marketcap
238,34ย โ‚ฌ
Share price
1.13%
Change (1 day)
-13.72%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company